# FDA Inspection 1009278 - Vitalant - March 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/vitalant/aef9dfd9-2c44-4872-b6b8-5e4afb67076a
Source feed: FDA_Inspections

> FDA Inspection 1009278 for Vitalant on March 29, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009278
- Company Name: Vitalant
- Inspection Date: 2017-03-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1227610 - 2023-12-22](https://www.keypedia.com/records/fda_inspections/vitalant/8402dbfb-c3c0-48b3-bb2e-83db9c812f9a)
- [FDA Inspection 579398 - 2009-04-22](https://www.keypedia.com/records/fda_inspections/vitalant/a089a244-270e-4b4b-a31a-1fa4c14f95fd)

Company: https://www.keypedia.com/companies/vitalant/0e177961-568d-4abd-80dd-3f8d03285923

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d